Coffee may prevent blepharospasm

Article

People who drink coffee are less likely to develop primary late onset blepharospasm.

People who drink coffee are less likely to develop primary late onset blepharospasm (BSP), according to a report published online ahead of print by the Journal of Neurology, Neurosurgery and Psychiatry.

Giovanni Defazio from the University of Bari, Italy and co-workers, investigated the effects of coffee and smoking in 166 patients with primary late onset BSP, 228 hospital control patients with primary hemifacial spasm and 187 population control subjects.

Unadjusted logistic regression analysis demonstrated a significant inverse association of prior coffee drinking and smoking with case status for the control groups. After adjusting for age, sex, disease duration, referral centre, years of schooling and coffee drinking/cigarette smoking, the smoking estimate lacked significance, whereas the association with coffee intake and BSP did not. The strength of the inverse association between BSP and coffee intake, tended to increase with the average number of cups drunk per day and there was a significant correlation between age of BSP onset and the number of cups per day, whereas no correlation was discovered with the number of packs of cigarettes per day.

It was concluded that coffee drinking may be inversely associated with the development of primary BSP and that this association may depend, in part, on the amount of coffee consumed.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.